Largest one day declines
The 50 largest one day percentage moves lower recorded at the latest close. The largest moves were 207940.KS at −6.8% and 0QF.DE at −6.8%. By size, the list splits into 14 mega cap and 36 large cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| 207940.KS | Samsung Biologics Co.,Ltd. | $50.14B | Large cap | −6.78% | −3.45% |
| 0QF.DE | Moderna, Inc. | $57.18B | Large cap | −6.77% | +520.84% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | −6.11% | +462.13% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | −5.77% | +496.25% |
| LLY.DE | Eli Lilly and Company | $1.05T | Mega cap | −4.41% | +65.95% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | −4.20% | +100.35% |
| 22UA.DE | BioNTech SE | $28.25B | Large cap | −4.10% | +9.41% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | −3.59% | +62.80% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −3.39% | −54.50% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | −3.38% | +3.61% |
| BOX.DE | Becton, Dickinson and Company | $51.76B | Large cap | −3.29% | −1.62% |
| BSX.DE | Boston Scientific Corporation | $68.45B | Large cap | −3.27% | −54.44% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −3.08% | −89.24% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | −3.05% | +71.81% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −3.02% | −13.32% |
| DC4.DE | DexCom, Inc. | $34.02B | Large cap | −2.32% | +17.96% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | −2.25% | +39.36% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $83.84B | Large cap | −2.24% | −8.02% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | −2.14% | +86.85% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | −2.13% | +1.37% |
| GSK.L | GSK plc | $101.26B | Large cap | −2.08% | +28.09% |
| GE9.DE | Genmab A/S | $20.71B | Large cap | −2.07% | −12.96% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | −2.07% | +46.30% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | −2.00% | +5.09% |
| NOV.DE | Novo Nordisk A/S | $206.12B | Mega cap | −1.98% | +12.94% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | −1.96% | +2.68% |
| ABVX.PA | ABIVAX Société Anonyme | $10.07B | Large cap | −1.86% | +46.14% |
| 4AB.DE | AbbVie Inc. | $457.78B | Mega cap | −1.84% | +29.91% |
| GMAB | Genmab A/S | $21.42B | Large cap | −1.78% | +36.20% |
| 7741.T | HOYA Corporation | $51.17B | Large cap | −1.76% | +28.99% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −1.75% | −11.83% |
| NOVO-B.CO | Novo Nordisk A/S | $206.43B | Mega cap | −1.67% | −13.55% |
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | −1.62% | +59.83% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | −1.60% | +1.27% |
| NVS | Novartis AG | $299.44B | Mega cap | −1.53% | +27.93% |
| RHO.DE | Roche Holding AG | $368.45B | Mega cap | −1.53% | +39.25% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −1.48% | −38.91% |
| CBHD.DE | Coloplast A/S | $16.10B | Large cap | −1.43% | +5.72% |
| AMG.DE | Amgen Inc. | $238.01B | Mega cap | −1.31% | +57.84% |
| BNTX | BioNTech SE | $28.28B | Large cap | −1.31% | +9.27% |
| SNY | Sanofi | $108.83B | Large cap | −1.30% | −4.33% |
| AZN.ST | AstraZeneca PLC | $255.60B | Mega cap | −1.29% | +3.69% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | −1.28% | +60.05% |
| GSK | GSK plc | $104.29B | Large cap | −1.23% | +32.23% |
| INCY | Incyte Corporation | $25.97B | Large cap | −1.23% | +51.01% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | −1.20% | +46.70% |
| PHI1.DE | Koninklijke Philips N.V. | $26.49B | Large cap | −1.20% | +2.20% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $22.30B | Large cap | −1.18% | +10.00% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | −1.15% | +55.40% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −1.11% | −17.31% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.